Omega is a leading international Life Sciences-focused investment firm operating from London and Boston offices.

We started our firm in 2004 by specializing in direct secondary transactions. Today we invest in late-stage opportunities, public and private companies on both sides of the Atlantic. We also continue to provide partial or complete liquidity or follow-on capital solutions for investors in the broad life sciences space: venture and growth equity firms, corporations and other institutions.

As part of our business, we provide follow-on capital to companies, founders and investment firms, as well as collaborate with universities with regards to leading start-ups and spin-off opportunities.